Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.44 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 2/20 | 0.35 |
| ▸ | CES1 | P23141 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Succinic Acid SCHEMBL28496469 | 0.85 | LMNA (0.50) | ALDH1A1TDP1FFAR3MEN1KMT2A | |
| SCHEMBL11742496 | 0.81 | — | — | |
| SCHEMBL16940181 | 0.81 | MEN1 (0.32) | ALDH1A1TDP1FFAR3MEN1KMT2A | |
| SCHEMBL2423505 | 0.77 | — | — | |
| SCHEMBL1245998 | 0.74 | — | — | |
| SCHEMBL4887740 | 0.74 | — | — | |
| SCHEMBL8712062 | 0.72 | CES2 (0.50) | ALDH1A1TDP1FFAR3MEN1KMT2A | |
| SCHEMBL1880913 | 0.72 | — | — | |
| SCHEMBL8057560 | 0.72 | — | — | |
| SCHEMBL5660160 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023196936-A1 | POLYNUCLEOTIDE CANCER VACCINE COMPOSITIONS AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-10-12 | — | — | WO | claimed |
| WO-2023196935-A1 | POLYNUCLEOTIDE VACCINE FORMULATIONS AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-10-12 | — | — | WO | claimed |
| EP-4221739-A1 | POLYNUCLEOTIDE VACCINES AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-08-09 | — | — | EP | claimed |
| EP-3597717-B1 | COATING PROCESS USING A POLYSULFIDE SEALANT COMPRISING CORE-SHELL PARTICLES | BOEING CO (US) | 2021-03-31 | — | — | EP | claimed |
| EP-3078718-B1 | CORE-SHELL PARTICLES, COMPOSITIONS INCORPORATING THE CORE-SHELL PARTICLES AND METHODS OF MAKING THE SAME | BOEING CO (US) | 2019-08-14 | — | — | EP | claimed |
| US-9856359-B2 | Core-shell particles, compositions incorporating the core-shell particles and methods of making the same | THE BOEING COMPANY (US) | 2018-01-02 | — | — | US | claimed |
| US-20160300646-A1 | CORE-SHELL PARTICLES, COMPOSITIONS INCORPORATING THE CORE-SHELL PARTICLES AND METHODS OF MAKING THE SAME | THE BOEING COMPANY | 2016-10-13 | — | — | US | claimed |
| EP-3078718-A2 | CORE-SHELL PARTICLES, COMPOSITIONS INCORPORATING THE CORE-SHELL PARTICLES AND METHODS OF MAKING THE SAME | The Boeing Company (US) | 2016-10-12 | — | — | EP | claimed |
| EP-2934909-A1 | RUBBER COMPOSITION COMPRISING CELLULOSE | Compagnie Générale des Etablissements Michelin (FR) | 2015-10-28 | — | — | EP | claimed |
| EP-2934910-A2 | RUBBER COMPOSITION COMPRISING CELLULOSE | Compagnie Générale des Etablissements Michelin (FR) | 2015-10-28 | — | — | EP | claimed |
| WO-2014096192-A2 | RUBBER COMPOSITION COMPRISING CELLULOSE | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2014-06-26 | — | — | WO | claimed |
| WO-2014096188-A1 | RUBBER COMPOSITION COMPRISING CELLULOSE | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2014-06-26 | — | — | WO | claimed |
| US-8344177-B2 | Albumin binding molecules and uses thereof | PHILOCHEM AG (CH) | 2013-01-01 | — | — | US | claimed |
| US-20100172844-A1 | ALBUMIN BINDING MOLECULES AND USES THEREOF | PHILOCHEM AG (CH) | 2010-07-08 | — | — | US | claimed |
| EP-2094647-A2 | ALBUMIN BINDING MOLECULES AND USES THEREOF | Philochem AG (CH) | 2009-09-02 | — | — | EP | claimed |
| WO-2008053360-A2 | ALBUMIN BINDING MOLECULES AND USES THEREOF | PHILOCHEM AG (CH) | 2008-05-08 | — | — | WO | claimed |
| CN-116916949-A | Polynucleotide vaccine and methods of use thereof | 伊穆农股份有限公司 | 2023-10-20 | — | — | CN | disclosed |
| WO-2023196935-A1 | POLYNUCLEOTIDE VACCINE FORMULATIONS AND METHODS OF USING THE SAME | Imunon, Inc. (US) | 2023-10-12 | — | — | WO | disclosed |
| EP-0704460-A1 | PROCESS FOR PRODUCING POLYMER TERMINATED WITH OPTIONALLY PROTECTED FUNCTIONAL GROUP | KURARAY CO., LTD. (JP) | 1996-04-03 | — | — | EP | disclosed |
| US-4399075-A | Process for producing chlorinated phenoxytoluene derivatives | ASAHI CHEMICAL COMPANY, LIMITED (JP) | 1983-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100172844-A1 | ALBUMIN BINDING MOLECULES AND USES THEREOF | ALB, FABP1, FABP2 | ALDH1A1 2026/4885TDP1 4688/4885FFAR3 4035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.